These findings further suggested that, as in head and neck cancer, inhibition of CBP/β-catenin signaling by small-molecule inhibitors ICG-001 or PRI-724 may exert antiproliferative and proapoptotic effects in melanoma. The gene discussed is CREBBP; the disease is melanoma.